Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,606.16 +1,184.30 (+1.73%) CMC Crypto 200
1,519.19 +30.65 (+2.06%)
Intellia Therapeutics, Inc. (NTLA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:21PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.50B |
| Enterprise value | 1.82B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 44.64 |
| Price/book (mrq) | 2.41 |
| Enterprise value/revenue | 34.55 |
| Enterprise value/EBITDA | -5.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.85 |
| 52-week change 3 | -40.41% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 47.48 |
| 52-week low 3 | 19.37 |
| 50-day moving average 3 | 24.84 |
| 200-day moving average 3 | 29.16 |
Share statistics
| Avg vol (3-month) 3 | 1.44M |
| Avg vol (10-day) 3 | 1.38M |
| Shares outstanding 5 | 96.48M |
| Implied shares outstanding 6 | 96.48M |
| Float 8 | 95.33M |
| % held by insiders 1 | 1.20% |
| % held by institutions 1 | 93.38% |
| Shares short (30 Apr 2024) 4 | 15.44M |
| Short ratio (30 Apr 2024) 4 | 12.75 |
| Short % of float (30 Apr 2024) 4 | 18.38% |
| Short % of shares outstanding (30 Apr 2024) 4 | 16.01% |
| Shares short (prior month 28 Mar 2024) 4 | 14.83M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -394.00% |
Management effectiveness
| Return on assets (ttm) | -24.15% |
| Return on equity (ttm) | -43.60% |
Income statement
| Revenue (ttm) | 52.6M |
| Revenue per share (ttm) | 0.58 |
| Quarterly revenue growth (yoy) | 129.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -507.9M |
| Net income avi to common (ttm) | -485.5M |
| Diluted EPS (ttm) | -5.37 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 791.29M |
| Total cash per share (mrq) | 8.2 |
| Total debt (mrq) | 110.86M |
| Total debt/equity (mrq) | 10.70% |
| Current ratio (mrq) | 9.03 |
| Book value per share (mrq) | 10.76 |
Cash flow statement
| Operating cash flow (ttm) | -405.42M |
| Levered free cash flow (ttm) | -256.11M |
© 2024 Yahoo. All rights reserved.